References
- Roy-Byrne PP, Wagner A. Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 2004;65\(Suppl 13):20–6
- Ansseau M, Dierick M, Buntinkx F, et al. High prevalence of mental disorders in primary care. J Affect Disord 2004;78:49–55
- Harman JS, Rollman BL, Hanusa BH, et al. Physician office visits of adults for anxiety disorders in the United States, 1985–1998. J Gen Intern Med 2002;17:165–72
- Belanger L, Ladouceur R, Morin CM. Generalized anxiety disorder and health care use. Can Fam Physician 2005;51:1362–3
- Wittchen HU, Kessler RC, Beesdo K, et al. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002;63(Suppl 8):24–34
- Stein MB, Sherbourne CD, Craske MG, et al. Quality of care for primary care patients with anxiety disorders. Am J Psychiatry 2004;161:2230–7
- Allgulander C, Bandelow B, Hollander E, et al. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectrums 2004;8(Suppl 1):53–61
- Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2001;62(Suppl 11):53–8
- Goodman WK. Selecting pharmacotherapy for generalized anxiety disorder. J Clin Psychiatry 2004;65(Suppl 13):8–13
- Koponen H, Allgulander C, Erickson J, et al. The efficacy of duloxetine for treatment of generalized anxiety disorder: implications for primary care physicians. Prim Care Comp J Clin Psychiatry. In press
- Rynn MA, Russell JM, Erickson J, et al. Efficacy and safety of duloxetine in treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depress Anxiety 2007 Feb 20; [Epub ahead of print] PMID: 17311303]
- Hartford J, Kornstein S, Liebowitz M, et al. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo- and active- controlled trial. Int Clin Psychopharmacology. In press
- Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–5
- Sheehan DV. The Anxiety Disease. New York: Charles Scribner and Sons, 1983
- Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiatry Med 1997;27:93–105
- Doyle AC, Pollack MH. Establishment of remission criteria for anxiety disorders. J Clin Psychiatry 2005;64(Suppl 15):40–5
- Pollack MH. Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission. J Clin Psychiatry 2001;62 (Suppl 19):20–5
- Beesdo K, Jacobi F, Wittchen HU. Generalized anxiety and pain: associations and implications. 2005; Poster presented at the American Collegium Neuropsychopharmacology annual conference, Hawaii
- Hoehn-Saric R. Psychic and somatic anxiety: worries, somatic symptoms and physiological changes. Acta Psychiatr Scand 1998;98:32–8
- Allgulander C, Koponen H, Erickson J, et al. Duloxetine as an effective treatment for improving painful physical symptoms and functioning associated with generalized anxiety disorder. 2006; Poster presented at the American Anxiety Disorders Association National Conference, Miami, FL
- Gartlehner G, Hansen RA, Carey TS, et al. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol 2005;20:59–69
- Meoni P, Hackett D, Lader M. Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder. Depress Anxiety 2004;19:127–32
- Hoehn-Saric R, McLeod DR, Funderburk F, Kowalski P. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study. Arch Gen Psychiatry 2004;61:913–21
- Rivas-Vazquez RA. Antidepressants as first-line agents in the current pharmacotherapy of anxiety disorders. Prof Psychol Res Pr 2001;32:101–4
- Rollman BL, Bellnap BH, Mazumdar S, et al Symptomatic severity of Prime-MD diagnosed episodes of panic and generalized anxiety disorder in primary care. J Intern Gen Med 2005;20:623–28
- Kessler RC, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002;63(Suppl 8):4–10